Manhard Kimberly insider trades
Manhard Kimberly has filed 21 Form 4s with the SEC that we hold, for Heron Therapeutics, INC. /DE/ (HRTX) (EVP, Drug Development), Inhibrx Biosciences, Inc. (INBX) (Director) and INBX (Director). Across all of them we count 1 purchase worth $139.8K and 6 sales worth $286.2K reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($279.0K). The largest single trade was a purchase of 10,000 shares of Inhibrx Biosciences, Inc. worth $139.8K, dated 2024-08-28. Of 5 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-15 and the latest 2026-09-18.
Heron Therapeutics, INC. /DE/ (HRTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-03 | S, sale reported on Form 4 | 1,504 | $7.2K | 2022-05-04 |
Inhibrx Biosciences, Inc. (INBX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-08-28 | P, purchase reported on Form 4 | 10,000 | $139.8K | 2024-08-30 |
| 2026-09-08 | S, sale reported on Form 4 | 500 | $57.6K | 2026-09-10 |
| 2026-09-09 | S, sale reported on Form 4 | 500 | $57.9K | 2026-09-10 |
| 2026-09-11 | S, sale reported on Form 4 | 500 | $55.9K | 2026-09-15 |
| 2026-09-14 | S, sale reported on Form 4 | 500 | $55.1K | 2026-09-15 |
| 2026-09-15 | S, sale reported on Form 4 | 500 | $52.5K | 2026-09-15 |
INBX (INBX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1202094) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms